Common Shares Outstanding: The number of class A shares currently held by investors.
Conduit Pharmaceuticals Inc. (CDT) had Common Shares Outstanding of 0.63M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.15M |
|
-- |
|
-- |
|
$4.01M |
|
$-4.01M |
|
$-1.14M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-4.01M |
|
$-3.45M |
|
0.26M |
|
0.26M |
|
$-19.79 |
|
$-19.79 |
|
| Balance Sheet Financials | |
$5.95M |
|
$0.04M |
|
$1.37M |
|
$7.32M |
|
$4.55M |
|
-- |
|
$0.09M |
|
$4.63M |
|
$2.69M |
|
$2.69M |
|
$2.69M |
|
|
Common Shares Outstanding |
0.63M |
| Cash Flow Statement Financials | |
$-4.33M |
|
$-0.00M |
|
$5.93M |
|
$0.55M |
|
$2.13M |
|
$1.58M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
0.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-191.51% |
|
-191.51% |
|
-70.29% |
|
-191.51% |
|
$4.24 |
|
$-16.72 |
|
$-16.70 |
|